Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome

Cristofori, F.; Thapar, N.; Saliakellis, E.; Kumaraguru, N.; Elawad, M.; Kiparissi, F.; Köglmeier, J.; Andrews, P.; Lindley, K. J.; Borrelli, O.

doi:10.1111/apt.12822

Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome

Summary Background Aprepitant (Emend, Merck Sharp & Dohme Ltd, Haarlem, the Netherlands), a neurokinin‐1 receptor antagonist, prevents vomiting in a range of conditions. No data are available on its use in children with cyclical vomiting syndrome ( CVS ). Aim We investigated the efficacy of aprep…